Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sonja Kappel"'
Autor:
Sonja Kappel-Latif, Prasanti Kotagiri, Lukas Schlager, Gabor Schuld, Natalie Walterskirchen, Vanessa Schimek, Gavin Sewell, Carina Binder, Johanna Jobst, Supriya Murthy, Barbara Messner, Stefanie Dabsch, Arthur Kaser, Paul A. Lyons, Michael Bergmann, Anton Stift, Rudolf Oehler, Lukas W. Unger
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 17, Iss 4, Pp 662-666 (2024)
Externí odkaz:
https://doaj.org/article/76bfdf33c2854d3bb95d4b5ee3cd5107
Autor:
Daniela Kandioler, Martina Mittlböck, Sonja Kappel, Harald Puhalla, Friedrich Herbst, Cord Langner, Brigitte Wolf, Jörg Tschmelitsch, Walter Schippinger, Günther Steger, Friedrich Hofbauer, Hellmut Samonigg, Michael Gnant, Bela Teleky, Irene Kührer
Publikováno v:
EBioMedicine, Vol 2, Iss 8, Pp 825-830 (2015)
We investigated the hypothesis that the varying treatment efficacy of adjuvant 5-fluorouracil (5FU) in stage III colon cancer is linked to the TP53 mutational status. ABCSG-90 was a prospective randomized trial in which effect of adjuvant 5FU was stu
Externí odkaz:
https://doaj.org/article/f32e15c90b3444429992ef780cd884c8
Autor:
Sonja, Kappel-Latif, Johannes, Zacherl, Michael, Hejna, Maria, Westerhoff, Dietmar, Tamandl, Ahmed, Ba-Ssalamah, Martina, Mittlböck, Brigitte, Wolf, Friedrich, Wrba, Irene, Kührer, Ursula, Pluschnig, Sebastian F, Schoppmann, Reinhold, Függer, Ronald, Zwrtek, Karl, Glaser, Josef, Karner, Friedrich, Längle, Etienne, Wenzl, Rudolf, Roka, Dietmar, Öfner, Jörg, Tschmelitsch, Michael, Hold, Felix, Keil, Michael, Gnant, Daniela, Kandioler, O, Dietze
Publikováno v:
European Surgery
Summary Background In operable esophageal cancer patients, neoadjuvant therapy benefits only those who respond to the treatment. The • Pancho trial represents the first prospective randomized trial evaluating the relevance of the mark53 status for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::388ec6af5a9c54a32a443414cd5c27dd
https://pubmed.ncbi.nlm.nih.gov/30559831
https://pubmed.ncbi.nlm.nih.gov/30559831
Autor:
Lindsay Brammen, Martina Mittlböck, Kausilia K. Krishnadath, Irene Kührer, Tamara Braunschmid, Wayne A. Phillips, Maria Westerhoff, Daniela Kandioler, Michael Gnant, Sonja Kappel-Latif
Publikováno v:
Annals of the New York Academy of Sciences, 1434(1), 46-53. Wiley-Blackwell
Technological progress within the last 15–20 years has significantly increased our knowledge about the molecular basis of cancer development, tumor progression, and treatment response. As a consequence, a vast number of biomarkers have been propose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb31d4028e4d845d563cef71eb378aee
https://pubmed.ncbi.nlm.nih.gov/30112858
https://pubmed.ncbi.nlm.nih.gov/30112858
Autor:
Jörg Tschmelitsch, Friedrich Hofbauer, Hellmut Samonigg, Sonja Kappel, Harald Puhalla, Cord Langner, Daniela Kandioler, Michael Gnant, Walter Schippinger, Bela Teleky, Irene Kührer, Friedrich Herbst, Günther G. Steger, Brigitte Wolf, Martina Mittlböck
Publikováno v:
EBioMedicine, Vol 2, Iss 8, Pp 825-830 (2015)
EBioMedicine
EBioMedicine
We investigated the hypothesis that the varying treatment efficacy of adjuvant 5-fluorouracil (5FU) in stage III colon cancer is linked to the TP53 mutational status. ABCSG-90 was a prospective randomized trial in which effect of adjuvant 5FU was stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53c77292431f8794193068dee1a0b941
http://www.sciencedirect.com/science/article/pii/S2352396415300359
http://www.sciencedirect.com/science/article/pii/S2352396415300359
Autor:
Raimund Jakesz, Elisabeth Janschek, Margaretha Rudas, Bela Teleky, Daniela Kandioler, Sonja Kappel, Brigitte Wolf
Publikováno v:
Breast Cancer Research and Treatment. 151:671-678
Li-Fraumeni syndrome (LFS) is a rare autosomal dominant inherited disorder associated with the occurrence of a wide spectrum of early-onset malignancies, the most prevalent being breast cancer and sarcoma. The presence of TP53 germline mutations in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4738202ece4bddd9b9cee217ee870ca
https://doi.org/10.1007/s10549-015-3424-1
https://doi.org/10.1007/s10549-015-3424-1
Autor:
Daniela Kandioler, Allan Clark, Brigitte Wolf, Junichi Akiyama, Danielle Straub, George Triadafilopoulos, Anushka Baruah, Anamay N. Sharma, Navtej S. Buttar, Ernest T. Hawk, Sheila Krishnadath, Raghav Chandra, Sonja Kappel, Asad Umar, Andrew Hart, Ishtpreet Singh, Leo Alexandre
Publikováno v:
Annals of the New York Academy of Sciences. 1325:108-126
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e78b9831c1748b83e6a40c0fff88ae9
https://doi.org/10.1111/nyas.12529
https://doi.org/10.1111/nyas.12529
Autor:
Irene Kührer, Brigitte Wolf, Rainer Schmid, Bela Teleky, Belgin Akan, Martina Mittlböck, Sonja Kappel, Daniela Kandioler, Fritz Wrba
Publikováno v:
European Surgery. 42:18-23
BACKGROUND: Cell killing by ionizing radiation is triggered by DNA-damage involving the p53 gene as major player in cell death induction. p53 is frequently inactivated in cancer which prevents apoptosis after extensive DNA-damage. METHOD: We summariz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2068f3a521d6dc32ff7a5e332b958f0f
https://doi.org/10.1007/s10353-010-0514-5
https://doi.org/10.1007/s10353-010-0514-5
Autor:
Sebastian F. Schoppmann, Johannes Zacherl, S. Gacic, Martina Mittlböck, Brigitte Wolf, Irene Kührer, Christoph Bichler, Sonja Kappel, Gerald W. Prager, Yelena Devyatko, Ahmed Ba-Ssalamah, Ursula Pluschnig, Michael Hejna, Fritz Wrba, Daniela Kandioler
Publikováno v:
European Surgery. 40:277-283
BACKGROUND: In esophageal cancer patients neoadjuvant therapy failed to demonstrate a clear benefit in overall survival. A significant advantage can be seen in patients with complete pathological response. METHODS: This review summarizes the results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07d40622340f33facf2b280552312fe8
https://doi.org/10.1007/s10353-008-0438-5
https://doi.org/10.1007/s10353-008-0438-5
Autor:
M.R. Müller, Erich Roth, Daniela Kandioler, Sabine Zöchbauer-Müller, Adelheid End, Marcus Hudec, Martina Mittlböck, T. Bachleitner, Wilfried Eberhardt, Ronald Zwrtek, Christoph Bichler, Irene Kührer, Georgios Stamatis, Sonja Kappel, Clemens Aigner, Walter Klepetko, Victoria Tichy
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 135:1036-1041
ObjectiveThe objective of this study is to establish clinical evidence that the p53 genotype can serve as a predictive marker for response to cisplatin-based induction therapy.MethodsPatients with advanced non–small cell lung cancer who had receive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ced428b941110269a9e51033ad12acd
https://doi.org/10.1016/j.jtcvs.2007.10.072
https://doi.org/10.1016/j.jtcvs.2007.10.072